TABLE 1.
Characteristics of ASCO Annual Meeting Abstracts and Authors, 2021-2023
| Characteristic | 2021 (n = 4,595), No. (%) | 2022 (n = 5,198), No. (%) | 2023 (n = 5,760), No. (%) | Overall (N = 15,553), No. (%) |
|---|---|---|---|---|
| Abstract track | ||||
| Cancer-specific tracks | 3,036 (66.1) | 3,460 (66.6) | 3,747 (65.1) | 10,243 (65.9) |
| Care delivery, quality, and health services | 612 (13.3) | 654 (12.6) | 796 (13.8) | 2,062 (13.3) |
| Developmental therapeutics | 494 (10.8) | 578 (11.1) | 643 (11.2) | 1,715 (11.0) |
| Medical education and professional development | 61 (1.3) | 78 (1.5) | 53 (0.9) | 192 (1.2) |
| Prevention, risk reduction, and genetics | 140 (3.0) | 143 (2.8) | 185 (3.2) | 468 (3.0) |
| Symptom science and palliative care | 252 (5.5) | 285 (5.5) | 336 (5.8) | 873 (5.6) |
| Presentation venue | ||||
| In person | 2,458 (53.5) | 2,854 (54.9) | 2,927 (50.8) | 8,239 (53.0) |
| Online only | 2,137 (46.5) | 2,344 (45.1) | 2,833 (49.2) | 7,314 (47.0) |
| Clinical trial ID | ||||
| Not present | 3,057 (66.5) | 3,366 (64.8) | 3,803 (66.0) | 10,226 (65.7) |
| Present | 1,538 (33.5) | 1,832 (35.2) | 1,957 (34.0) | 5,327 (34.3) |
| First author institution region | ||||
| North America | 2,598 (56.5) | 2,939 (56.5) | 3,362 (58.4) | 8,899 (57.2) |
| East Asia and Pacific | 925 (20.1) | 1,094 (21.0) | 1,231 (21.4) | 3,250 (20.9) |
| Europe and Central Asia | 838 (18.2) | 899 (17.3) | 854 (14.8) | 2,591 (16.7) |
| Latin America and Caribbean | 98 (2.1) | 100 (1.9) | 134 (2.3) | 332 (2.1) |
| Middle East, North Africa, and Sub-Saharan Africa | 65 (1.4) | 74 (1.4) | 89 (1.5) | 228 (1.5) |
| South Asia | 71 (1.5) | 92 (1.8) | 90 (1.6) | 253 (1.6) |